ACCESS CHINA Forum 2021

Day 1 – Opening Speech_AC 2021

1
Opening Speech & China Biotech Innovation – Jeffrey Zhang, Chair (CHBD)
开幕致辞 & 中国生物技术创新 – 张继国 (CHBD, 会长)

2

Cross-border Licensing Annual review – Sean Jiang, CEO (YAFO Capital)

医药跨境交易年度汇总 – 蒋晓阳 (雅法资本, CEO)

3

New Era of Innovation and Differentiation
      Jiaxi Xu, Chief Pharmaceutical Analyst (Industrial Securities)
创新与差异化的新时代
      徐佳熹 (兴业证券,  医药行业首席分析师)
4
Bio Century Commercial Section- The Evolution of China Pharma Market
      Tina Hou, Global Partner (Mckinsey)
中国医药市场的演变
      侯蕾 (麦肯锡,  全球合伙人)


5
Global Transaction Experience – MNC Perspective
      Cynthia Wang, BD&Licensing Director (Servier)
全球医药交易经验-跨国药企角度分享
      王昕 (施维雅,  亚太生物创新中心业务拓展及许可总监)


6
Japan Market Opportunity for Chinese Pharmas
      Steve Engen, Founder & President (Renexes)
中国制药公司在日本市场机会
      Steve Engen (Renexes,  创始人&主席)
7
Investment Strategy for the Pharmaceutical Industry: Innovation + Import Substitution Lead the Great Era of Pharmaceuticals
      Xiangyang Du, Chief Pharmaceutical Analyst (South West Securities)
双循环背景下,创新升级+进口替代引领医药大时代
      杜向阳 (西南证券,  医药行业首席分析师)
8
Pharma BD in China
      Kui Wang, Secretary General (CHBD)BD的一段到九段修炼
      汪奎 (CHBD,  秘书长)
%d bloggers like this: